AgomAb Therapeutics CEO reports Form 4P purchase
Form 4P filed by AgomAb Therapeutics NV shows CEO Tim Jasper P Knotnerus purchased 11,000 shares at $8.58 for $94,380.
Story updates
12:10:51 PM UTC
SquawkNews
CEO Knotnerus Buys 11,000 Of AgomAb Therapeutics NV >AGMB